companydata.dkcompanydata.dk

DERMA PHARM A/S: Financial statements 2023

CVR: 89453119

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

DERMA PHARM A/S (CVR 89453119) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 81,333,290 and a net result of DKK 9,574,416 compared with DKK 4,022,422 the year before. That is an increase of 14.2% compared with the year before. Equity in the 2023 report amounted to DKK 46,603,486. The solvency ratio was 35.9%. The company had 117 employees in the financial year.

Gross Profit
DKK 81,333,290
Profit/Loss
DKK 9,574,416
Equity
DKK 46,603,486
Total Assets
DKK 129,793,808
Employees
117

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-81.3 mio.9.6 mio.46.6 mio.117
2022-71.2 mio.4 mio.39.5 mio.121
2021-70.7 mio.7.2 mio.39.6 mio.115
2020-76.2 mio.12 mio.40.5 mio.108
2019-63.5 mio.6.1 mio.32.6 mio.105

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

DERMA PHARM A/S appoints new auditorSep 20, 2023

As of September 20, 2023, A/S PSE 17 NR. 1056 has been appointed auditor of DERMA PHARM A/S.

Auditor steps down at DERMA PHARM A/SSep 20, 2023

As of September 20, 2023, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of DERMA PHARM A/S.

DERMA PHARM A/S: The 2022 annual report is outJul 3, 2023

DERMA PHARM A/S has published its annual report for 2022. Gross profit came to DKK 71,192,456, and the net result was DKK 4,022,422.

About DERMA PHARM A/S

DERMA PHARM A/S is a Danish company of the type Aktieselskab based in Fårup, founded in 1980. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The company was previously named GENSAN DERMAPHARM A/S and GENSAN HYGIEJNE A/S. The management consists of Mikkel Egelund Jensen and Peter Bogh. The board consists of Jean-Yves Paul Etienne Desmottes (chair), Magdalena Jurkiewicz, Marie Anne Louise Bozec and Massimiliano Costantini. The company is owned by DERMAPHARM HOLDING A/S. The company has 138 employees (2026). In 2025, the company reported a gross profit of DKK 122,113,000 and a net result of DKK 28,500,000 compared with DKK 18,538,000 the year before. Equity in the 2025 report amounted to DKK 78,142,000.

Source: annual report 2025, Danish Business Authority